Literature DB >> 24041653

Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.

Xu Sun1, Yong He, Cheng Huang, Tao-Tao Ma, Jun Li.   

Abstract

As the crucial biological regulators, microRNAs that act by suppressing their target genes are involved in a variety of pathophysiological processes. It is generally accepted that microRNAs are often dysregulated in many types of neoplasm and other human diseases. In neoplasm, microRNAs may function as oncogenes or tumor suppressors. As constitutive activation of the Wnt signaling pathway is a common feature of neoplasm and contributes to its development, progression and metastasis in various cancers, numerous studies have revealed that microRNA-mediated gene regulation are interconnected with the Wnt/β-catenin signaling pathway, forming a Wnt/β-catenin-microRNA regulatory network, which is critical to successful targeting of the Wnt/β-catenin pathway for oncotherapy. In this review, we aim to accumulate recent advances on microRNAs that work in tandem with Wnt/β-catenin signaling in tumorigenesis, with particular focus on how microRNAs affect Wnt/β-catenin activity as well as how microRNAs are regulated through the Wnt/β-catenin pathway.
© 2013.

Entities:  

Keywords:  APC; Adenomatous polyposis coli; CK1α; Casein kinase 1α; DKK; Dickkop; Disheveled; Dvl; EZH2; FZD; Frizzled; GSK3β; Glycogen synthase kinase 3β; HCC; Hepatocellular carcinoma; IRS; Insulin receptor substrate; LDL receptor–related protein; LEF; LRP; Lymphoid enhancer-binding factor; NLK; Nemo-like kinase; Neoplasm; Secreted frizzled-related proteins; T-cell factor; TCF; WIF; Wnt inhibitory factor; Wnt/β-catenin signaling; Wnt–microRNA regulatory network; Zeste homologue 2; miRs; microRNA; microRNAs; sFRPs

Mesh:

Substances:

Year:  2013        PMID: 24041653     DOI: 10.1016/j.cellsig.2013.09.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  18 in total

Review 1.  microRNA regulation of Wnt signaling pathways in development and disease.

Authors:  Jia L Song; Priya Nigam; Senel S Tektas; Erica Selva
Journal:  Cell Signal       Date:  2015-04-02       Impact factor: 4.315

2.  Up-regulation of small nucleolar RNA 78 is correlated with aggressive phenotype and poor prognosis of hepatocellular carcinoma.

Authors:  Pei Ma; Haitao Wang; Lu Han; Wei Jing; Xin Zhou; Zhisu Liu
Journal:  Tumour Biol       Date:  2016-10-21

3.  [Yiqihuoxue prescription promotes nerve regeneration by miR-124-mediated regulation of Wnt signaling in rats].

Authors:  Hui Tan; Jian Wang; Ting-Ting Yin; Ling He; Yong Deng; Feng Li; Yu-Feng Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

4.  Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.

Authors:  Qiang Sun; Shu Guo; Chen-Chao Wang; Xu Sun; Di Wang; Nan Xu; Shi-Feng Jin; Ke-Zhu Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 5.  Role of epithelial-mesenchymal transition in gastric cancer initiation and progression.

Authors:  Zhao Peng; Chen-Xiao Wang; Er-Hu Fang; Guo-Bin Wang; Qiang Tong
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 6.  Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma.

Authors:  Min Yao; Li Wang; Yao Yao; Hong-Bing Gu; Deng-Fu Yao
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

7.  Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis.

Authors:  Josephraj Sophia; Kranthi Kiran Kishore T; Jaganathan Kowshik; Rajakishore Mishra; Siddavaram Nagini
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

8.  The Wnt antagonist sFRP1 as a favorable prognosticator in human biliary tract carcinoma.

Authors:  Pengcheng Kang; Ming Wan; Peng Huang; Chunlong Li; Zhidong Wang; Xiangyu Zhong; Zhanliang Hu; Sheng Tai; Yunfu Cui
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

9.  MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.

Authors:  Yi Zhang; Changwei Lin; Guoqing Liao; Sheng Liu; Jie Ding; Fang Tang; Zhenran Wang; Xingsi Liang; Bo Li; Yangchao Wei; Qi Huang; Xuan Li; Bo Tang
Journal:  Oncotarget       Date:  2015-10-20

10.  Selective Retention of an Inactive Allele of the DKK2 Tumor Suppressor Gene in Hepatocellular Carcinoma.

Authors:  Yung-Feng Lin; Ling-Hui Li; Chih-Hung Lin; Mei-Hua Tsou; Ming-Tai Kiffer Chuang; Keh-Ming Wu; Tsai-Lien Liao; Jian-Chiuan Li; Wei-Jie Wang; Angela Tomita; Beverly Tomita; Shiu-Feng Huang; Shih-Feng Tsai
Journal:  PLoS Genet       Date:  2016-05-20       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.